Loading grant details…
Completed
TRAINING, INDIVIDUAL
NIH (US)
Harnessing the innate immunotransmitter cGAMP for anti-cancer therapy
$135.4K
USD
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | Stanford University |
| Country | United States |
| Start Date | Apr 01, 2021 |
| End Date | Sep 30, 2021 |
| Duration | 182 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10372839 |
Grant Description
PROJECT SUMMARY/ABSTRACT No change from original proposed activities.
All Grantees
Stanford University
Advertisement
Advertisement
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Start Year
2021
End Year
2021
Grantees
1
Related Grants
Individualized Profiles of Sensorineural Hearing Loss from N...
NATIONAL INSTITUTE ON DEAFNESS AND OTHER...
$999.3K USD
Financial Toxicity in Chronic Obstructive Pulmonary Disease
NATIONAL HEART, LUNG, AND BLOOD INSTITUT...
$973.6K USD
The Effect Of Structural Racism On Racial And Geographic Dis...
NATIONAL INSTITUTE OF DIABETES AND DIGES...
$973.6K USD
Advertisement
